Advances In Vitiligo Treatment

March 2026 in “ International Journal of Dermatology Venereology and Leprosy Sciences ”

Aya Amr Mohamed Sedky Elkady, Ghada Fawzy Rezk, Engi Seif E. Shaker, Zeinab Abdel Samd Ibrahim

Studysummary This study describes vitiligo as an autoimmune disease marked by depigmented skin and mucosal patches, and reviews its complex pathogenesis and diagnostic features. Treatment aims for disease control and repigmentation through various topical and systemic therapies, phototherapy, and surgical options, emphasizing personalized, multimodal approaches.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on dermatologypaper.com →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research What’s new in the treatment of vitiligo

8 citations , July 2001 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”

This review summarizes the historical and evolving treatments for vitiligo, highlighting that combining medical and surgical approaches may enhance repigmentation outcomes, though more research and new protocols are needed.

research Advanced Therapy Medicinal Products in Vitiligo; Current Status, Future Prospect, and Approved Treatments.

5 citations , March 2023 in “PubMed”

This review discusses the potential of advanced therapy medicinal products for treating vitiligo, highlighting promising results but noting affordability remains a challenge; no new clinical results were reported.

research CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW

March 2026 in “International Journal of Innovative Technologies in Social Science”

This review highlights advancements in vitiligo treatment, noting improved diagnostic techniques and the emergence of targeted therapies like Janus Kinase inhibitors, which may offer more effective management of this complex autoimmune skin disorder.

research Updates in Vitiligo

1 citations , January 2025 in “Updates in clinical dermatology”

New treatments for vitiligo, including the first FDA-approved option, are improving patient care and quality of life.

research Vitiligo—Current Treatment Options and Future Perspectives

July 2026 in “International Journal of Molecular Sciences”

This review highlights that a comprehensive approach combining pharmacological, immunomodulatory, and regenerative interventions, including phototherapy enhanced with topical treatments and JAK inhibitors, appears effective and promising in the management of vitiligo by addressing its autoimmune and melanocyte-loss aspects.